Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31731374)

  • 1. Lung adenocarcinoma pathology stages related gene identification.
    Sun GZ; Zhao TW
    Math Biosci Eng; 2019 Oct; 17(1):737-746. PubMed ID: 31731374
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-expression network analysis identified KIF2C in association with progression and prognosis in lung adenocarcinoma.
    Bai Y; Xiong L; Zhu M; Yang Z; Zhao J; Tang H
    Cancer Biomark; 2019; 24(3):371-382. PubMed ID: 30883337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
    Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated mRNA Levels of AURKA, CDC20 and TPX2 are associated with poor prognosis of smoking related lung adenocarcinoma using bioinformatics analysis.
    Zhang MY; Liu XX; Li H; Li R; Liu X; Qu YQ
    Int J Med Sci; 2018; 15(14):1676-1685. PubMed ID: 30588191
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
    Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
    J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of activated pathways in lung adenocarcinoma based on network strategy.
    Yu B; Li T; Chen J; Wang FQ; Fu JH; Liu SM; Wang Y; Zhang X; Yang HT
    J Cancer Res Ther; 2020; 16(4):793-799. PubMed ID: 32930120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
    Ni KW; Sun GZ
    Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
    Liang J; Lv J; Liu Z
    Tumour Biol; 2015 Aug; 36(8):6391-9. PubMed ID: 25861020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Genes Associated with Lung Adenocarcinoma Prognosis.
    He ZH; Lv W; Wang LM; Wang YQ; Hu J
    Comb Chem High Throughput Screen; 2019; 22(4):220-224. PubMed ID: 30947660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel strategy of integrated microarray analysis identifies CENPA, CDK1 and CDC20 as a cluster of diagnostic biomarkers in lung adenocarcinoma.
    Liu WT; Wang Y; Zhang J; Ye F; Huang XH; Li B; He QY
    Cancer Lett; 2018 Jul; 425():43-53. PubMed ID: 29608985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel glycolysis-related gene signature for predicting metastasis and survival in patients with lung adenocarcinoma.
    Zhang L; Zhang Z; Yu Z
    J Transl Med; 2019 Dec; 17(1):423. PubMed ID: 31847905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription Factors Contribute to Differential Expression in Cellular Pathways in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Liu S; Wang X; Qin W; Genchev GZ; Lu H
    Interdiscip Sci; 2018 Dec; 10(4):836-847. PubMed ID: 30039492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma.
    Zengin T; Önal-Süzek T
    BMC Bioinformatics; 2020 Sep; 21(Suppl 14):368. PubMed ID: 32998690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.
    Wu S; Wu D; Pan Y; Liu H; Shao Z; Wang M
    Pathol Res Pract; 2019 Feb; 215(2):292-301. PubMed ID: 30527357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene coexpression analysis offers important modules and pathway of human lung adenocarcinomas.
    Wei Z; Zhongqiu T; Lu S; Zhang F; Xie W; Wang Y
    J Cell Physiol; 2020 Jan; 235(1):454-464. PubMed ID: 31264215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
    Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
    BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
    Yu Y; Tian X
    Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.